Lichter Jay
SEC insider (Form 3/4/5 filer). CIK 0001376355. 10% Owner at Janux Therapeutics, Inc. (JANX). 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 13, 2024. Located in LA JOLLA, CA.
Companies Lichter Jay has filed insider reports for
- Janux Therapeutics, Inc. (JANX): 10% Owner
Lichter Jay
CIK: 0001376355
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (20.0%)
Position reduction
Option Exercises (M)4 (80.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JANX
Janux Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 13, 2024JANX
Janux Therapeutics, Inc.
ExerciseDirect1.9K shares at avg. $17.00$32K - Sep 13, 2024JANX
Janux Therapeutics, Inc.
ExerciseDirect778 shares at avg. $10.73$8K - Sep 13, 2024JANX
Janux Therapeutics, Inc.
ExerciseDirect778 shares at avg. $13.22$10K - Sep 13, 2024JANX
Janux Therapeutics, Inc.
ExerciseDirect391 shares at avg. $39.80$16K - Sep 13, 2024JANX
Janux Therapeutics, Inc.
SaleDirect3.8K shares at avg. $46.68$178K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | Exercise | 1,868 | $17.00 | $31,756 | Direct |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | Exercise | 778 | $10.73 | $8,348 | Direct |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | Exercise | 778 | $13.22 | $10,285 | Direct |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | Exercise | 391 | $39.80 | $15,562 | Direct |
| Sep 13, 2024 | JANX Janux Therapeutics, Inc. | Sale | 3,815 | $46.68 | $178,084 | Direct |
1-5 of 5 transactions